Population study of urban, rural and semi-urban regions to assess the prevalence of risk factors conducive to endovascular disease and its incidence for holistic intervention – PURSE HIS Cohort Study  by Thanikachalam, S. et al.
Epidemiology & Prevention
Population study of urban, rural and
semi-urban regions to assess the
prevalence of risk factors conducive to
endovascular disease and its incidence
for holistic intervention – PURSE HIS
Cohort Study
S. Thanikachalam *, V. Harivanzan, C. Anbarasi,
Aashish Chopra, G. Nagarjuna, P. Sundararaju,
J. Sathya Narayanan Murthy, T.R. Muralidharan
Sri Ramachandra University, Porur, Chennai 600116, India
Background: Cardiovascular disease and stroke are two leading
causes for deaths (42.6%) due to non-communicable diseases.
The WHO emphasizes the need for early detection of multiple
risk factors which alter vascular biology relentlessly to intervene
early at population level to thwart the impending catastrophic
vascular events. To achieve this, a well-designed population
research encompassing all economic strata of society is man-
datory.
Materials and methods: Study design: Multistage stratiﬁed rando-
mised cluster sampling; Study setting: Urban (Chennai), semi-urban
and rural areas from Thiruvallur and Kanchipuram districts of
Tamil Nadu. Study population: Inmates of an individual house
makes the sampling unit. Sample size: 8080 study participants of
both gender with age 20–65 years.Methods: The participants under-
went clinical, biochemical, imaging and biomarker estimation for
occult and overt endovascular disease. The study was approved by
the IEC, registered in CTRI (CTRI/2011/04/001677) and funded by
DST, Govt. of India.
Results Among the recruited 8080, with a mean age of 45 years,
56.4% of them had an average of 3–4 family members.
i n d i a n h e a r t j o u r na l 6 7 ( 2 0 1 5 ) s 1 0 9 – s 1 1 6
S.no. Variable In percentage S.no. Variable In percentage
Urban Semi-urban Rural Urban Semi-urban Rural
1 Study participants 27.48 34.91 37.61 22 High homocysteine 28.03 27.81 28.32
2 Males 44.9 43 44 23 High hs-CRP 37.23 38.57 34.93
3 Females 55.1 57 56 24 High microalbumin 17.32 14.81 15.29
4 Smoking (Males) 25.8 23.8 38.3 25 Uric acid 4.84 1.97 4.92
5 Obesity$ 47.92 53.63 28.34 26 High Lp(a) level 33.17 39.72 34.11
6 Increased Waist hip ratio$ 73.37 56.16 47.51 27 Depression@ 9.7 8.88 7.09
7 High skin fold thickness 77.87 85.81 71.90 28 Anxiety@@ 19.82 17.06 13.05
8 Increased body fat % 81.01 85.44 64.95 29 Life event 20.64 16.13 15.14
9 Low physical activity 23.17 22.94 19.32 30 Stress 8.20 13.55 13.98
10 Newly detected DM 5.44 5.34 6.35 31 Abnormal resting ECG# 15 10 7
11 Known DM 13.88 12.48 5.7 32 Abnormal stress ECG 10.6 7.5 6.3
12 Total DM½ 19.32 17.82 12.05 33 Abnormal wall motion 2.23 4.41 6.74
14 IGT 3.38 8.33 6.43 34 Abnormal AB index 6.85 10.41 7.89
15 IFG and IGT 15.31 23.25 24.23 35 High ASP® 24.26 18.29 20.58
16 HbA1c above 6 36.2 46 34.8 36 High APP® 23.67 18.32 22.26
17 Insulin resistance-HOMA 30.84 28.78 18.04 37 High AAP® 16.02 13.16 22.59
18 Hypertension£ 18.64 18.1 15.24 38 High AIx® 19.29 18.57 18.29
19 Pre-hypertension£ 31.35 42.31 23.91 39 Abnormal PWV® 19.72 13.36 10.14
20 Lipid abnormality$ 72.1 61.26 61.17
21 Metabolic syndrome* 23.29 22.6 12.49
Note: ½ ADA criteria; £ JNC-7 criteria; $ ICMR guideline; *WHO criteria; $ Total cholesterol ≥200, TGL ≥150, LDL ≥130 or HDL<40; @ Hamilton
Depression Rating Scale; @ @ Hamilton Anxiety Rating Scale; # Minnesota classiﬁcation; ® SphygmCor MM3. ASP-Aortic systolic pressure; APP –
aortic pulse pressure; AAP – aortic augmented pressure; AIx – augmentation index; PWV – pulse wave velocity.




Conclusion This study reveals nearly 30% of the population are
under exposure with multiple risk factors with rising risk gradient
from rural to urban regions, presence of occult and overt altered
vascular biology indicating inﬂuence of environmental factors.
The data emphasizes the need for such studies in different regions
across the country to evolve strategic plan at population level for
early identiﬁcation and intervention to thwart untimely vascular
death.
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Background: Limited data are available to assesswhether access to
and quality of cardiovascular disease (CVD) care are comparable
among men and women in India. We analyzed data from the
American College of Cardiology's PINNACLE (Practice Innovation
and Clinical Excellence) India Quality Improvement Program
(PIQIP) to evaluate gender disparities in CVD care delivery.
Methods and results: Between 2011 and 2015, we collected data on
performance measures for patients with coronary artery disease
(CAD) (n = 14,010), heart failure (HF) (n = 11,965) and atrial ﬁbrilla-
tion (AF) (n = 496) in PIQIP, among 17 participating practices.
The total number of women was 5,301 (20.0% of the cohort). The
number of patient encounters were signiﬁcantly low for women
compared to men (2.59 vs. 2.82, p = <0.001). Women were signiﬁ-
cantly younger (48.9 years vs. 51.5 years, p = <0.001), but had a
higher co-morbidity burden compared to men – hypertension
(62.0% vs. 45.6%, p = <0.001), diabetes (39.4% vs. 35%, p = <0.001),
and hyperlipidemia (3.7% vs. 3.1%, p = 0.19). On the contrary, the
medication prescription rateswere strikingly lower inwomenwith
CAD compared to men – aspirin (38% vs. 50.4%, p = <0.001), aspirin
or thienopyridine combination (46.9% vs. 57.2%, p = <0.001), and
beta-blockers (36.8% vs. 47.8%, p = <0.001). Similarly, among
women with ejection fraction <40%, the use of guideline-directed
medical therapywas signiﬁcantly lower compared tomen for beta-
blockers (30.8% vs. 37.0%, p = <0.001), angiotensin-converting
enzyme inhibitors (ACE-i) or angiotensin receptor blockers (ARBs)
(29.3% vs. 34.9%, p = <0.001), and beta-blockers/ACE-i or ARBs
(24.6% vs. 31.0%, p = <0.001). Among patients with AH and CHADS2
score ≥2, more women were on oral anticoagulation (19.6% vs.
14.6%, p = 0.34), although this was not signiﬁcantly different
between men and women, and the overall number of patients
with AH was low.
Conclusions: Although documentation of guideline-directed med-
ical therapy was low for both genders, signiﬁcant gender dispa-
rities exist in CVD care access and delivery in India, with a
strikingly low percentage of women receiving guideline-directed
CVD medical therapy compared to men, despite a signiﬁcantly
higher co-morbidity burden. These ﬁndings should provide
impetus to identify potential causes for, and seek solutions to
narrow these disparities.
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Background: With the increase of cardiovascular risk factors in
India the prevalence of coronary heart disease is also expected to
rise. A cross sectional study in 2010–2012 assessed the prevalence
of coronary heart disease in Kaniyambadi, a rural block and urban
Vellore, Tamil Nadu and compared the current prevalencewith the
prevalence of coronary heart disease in the same areas in 1991–
1994.
Two cross sectional surveys were carried out to determine the
prevalence of coronary heart disease in a rural block in Vellore
district and in Vellore town in 1991–1994 and 2010–2012. The
numbers of participants were 7342 in 1991–1994 and 4845 in
2010–2012, aged 30–60 years. Coronary heart disease was deﬁned
as previously diagnosed, symptoms detected using Rose angina
questionnaire or ischemic changes on electrocardiography (ST, T
and Q wave changes, read by trained cardiologists).
The age adjusted prevalence in rural women nearly tripled and
urban women doubled, with only a slight increase among males,
between 1991–1994 and 2010–2012 in both urban and rural Vellore,
south India.
The large increase in prevalence rates of coronary heart disease
among women, suggests the need for further conﬁrmatory studies
and interventions for prevention, especially targeting women who
are generally considered to be at a lower risk for coronary heart
disease.
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Introduction: Coronary artery disease (CAD) is the leading cause of
morbidity and mortality in the present world. Risk factor assess-
ment, prevention and treatment of CAD is an important aspect of
present day research. CHADS2 and CHA2DS2-VASc scores have
been previously used for assessing prognostic risk of thromboem-
bolism in non valvular atrial ﬁbrillation patients. They include
similar risk factors for the development of CAD and may provide
crucial information regarding the severity of coronary artery
lesions. To increase the likelihood of determining CAD severity,
the CHA2DS2-VASc-HS and CHA2DS2-VASc-HSF score comprising
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